Navigation Links
IR BioSciences Announces Data Demonstrating Radilex Stimulation of,Stem Cells Results in Hematopoietic Recovery Following Lethal,Irradiation

Animal Data Shows Prolonged Survival AND Increased Platelet Concentrations

SCOTTSDALE, Ariz., March 08, 2007 /PRNewswire-FirstCall/ -- ImmuneRegen BioSciences, a wholly-owned subsidiary of IR BioSciences Holdings, Inc. announced today that ongoing analysis of data acquired from previously performed animal efficacy studies has revealed evidence that ImmuneRegen's developmental stage product, Radilex(TM), may stimulate hematopoietic stem cells.

Studies performed at the Oak Ridge National Laboratory reveal that ImmuneRegen's potential radioprotectant product, Radilex, not only prolonged survival of animals exposed to lethal gamma irradiation, but appeared to have increased platelet concentrations in surviving animals. As the experimental protocol required these animals to be subject to repeated blood sampling as well as irradiation, saline injections were relied on for plasma volume restoration. In the face of the resulting hemodilution, compensatory hematopoietic mechanisms were nonetheless adequately stimulated to enable survival of a number of Radilex-treated, but no untreated, animals. Blood cell quantitation showed trends in the surviving animals toward neutrophil replenishment as well. ImmuneRegen has since filed a provisional patent entitled "Method to Treat Blood Cell Depletion" to provide intellectual property protection for this finding regarding Radilex.

Continuing radiation studies will be performed at both the Translational Genomics Research Institute (TGen) and TGen Drug Development Services (TD2, its drug development arm) and at the Pacific Northwest National Laboratory to further explore the impact of radiation on the hematopoietic system of Radilex-exposed animals. ImmuneRegen's ongoing studies will be designed to examine mechanistic indicators at both high levels of radiation where Radilex has shown protection, as well as at lower levels. If successful, these studies will enable Rad
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
4. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
5. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
6. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
7. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
8. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ... Reputation of Pharma in 2014 - a Perspective of ... to their offering. For the first time, ... corporate reputation of the pharmaceutical industry held by patient ... views of patient organisations representing all therapy areas. ...
(Date:4/17/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused ... the treatment of cancer and diseases of the central ... three of its most advanced oncology programs at the ... Annual Meeting being held from April 18-22, 2015 ... The presentation on the BNC105 program describes ...
(Date:4/16/2015)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), a ... products for the treatment of central nervous system disorders, ... quarter of 2015 on Wednesday, May 6, 2015, after ... host a conference call at 4:30 PM ET on ... discuss the first quarter 2015 financial results and other ...
Breaking Medicine Technology:Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2
(Date:4/17/2015)... Enthusiasts of gourmet cuisine and beverages will ... 2015. The event will be held in the heart of ... Ave NW, Grand Rapids, MI 49503) and will feature wine ... Patrons are encouraged to savor the food and beverage pairings ... year’s event will feature seven chefs, including:, ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Baptist Health ... have signed a partnership agreement designed to transform oncology ... The institutions have agreed to create a joint cancer ... protocols and translational research. Baptist MD Anderson Cancer Center ... providing a single destination for highly coordinated, multidisciplinary cancer ...
(Date:4/17/2015)... 17, 2015 Calvary Hospital recently announced Timothy ... Executive Vice President on May 11. The Fund directs all ... mission. Barr succeeds Vincent J. Spinelli, who retired several months ... take on and supervise the important work that the Fund ... “As Calvary continues to expand and bring our signature care ...
(Date:4/17/2015)... Nomedexamlifeinsurance.com has released a new blog post explaining how ... , Smoking is linked to numerous diseases like cancer ... smokers more money for life insurance plans. Someone who ... can qualify for advantageous offers. , The life ... non-smokers. Comparing quotes is the best method of reducing ...
(Date:4/17/2015)... Verndale, a Global Experience Technology Company, ... been chosen as a Boston Business Journal (BBJ) Pacesetter, ... the region. The BBJ’s Pacesetters represents privately held businesses ... 2014. This is the eighth consecutive year and the ... has been honored with this award. , “Being honored ...
Breaking Medicine News(10 mins):Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 2Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 3Health News:Life Insurance Quotes for Smokers Available Online 2Health News:Verndale Honored as 2015 Boston Business Journal Pacesetter, Named 46th Fastest Growing Private Company 2
... BioFit Engineered Products, an Ohio-based manufacturer and long-standing leader in ... and Atmospheric Administration (NOAA) with a solution to a unique ... habitat. , ... Bowling Green, OH ...
... expansion of its Sealy office. , ... Sealy, Texas (PRWEB) January 8, ... Sealy office. Located on Meyer Street the five-year old-practice has blossomed reaching ... of the surrounding communities as well., , , , ,The eye ...
... Service Employees,International Union (SEIU) announced the formation of the ... the patients that they serve,a greater voice as we ... nation,s,history. , Since adoption of ... made,numerous jurisdiction decisions that have helped members who do ...
... Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" ... and personal care products company announced that on January ... stock repurchase fund according to the terms approved by ... up to Ps. 100 million pesos. Company Description ...
... EXTON, Pa., Jan. 9 Kensey Nash Corporation (Nasdaq: ... release its earnings results for its second quarter ended ... Wednesday, January 28, 2009. Joe Kaufmann, President and ... results on Wednesday, January 28, 2009 at 9:00 A.M. ...
... study found, , , FRIDAY, Jan. 9 (HealthDay News) -- If ... cut your risk of dying from flu in half, research ... perfect match for the strains circulating in any given year, ... that included 10 flu seasons, worth of data also found ...
Cached Medicine News:Health News:BioFit 1Y Takes the Plunge to Fill Undersea Seating Role for NOAA 2Health News:Austin County Eye Expands Sealy Eye Clinic Office 2Health News:Statement From SEIU International President Andy Stern on UHW Leaders' Response to the Jurisdiction Decision 2Health News:Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference 2Health News:You're Never Too Old for a Flu Shot 2Health News:You're Never Too Old for a Flu Shot 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: